The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III trial of brentuximab vedotin and CHP versus CHOP in the frontline treatment of patients (pts) with CD30+ mature T-cell lymphomas (MTCL).
 
Owen A. O'Connor
Honoraria - Millennium; Mundipharma; Novartis; Seagen
Consulting or Advisory Role - Allos Therapeutics; Millennium; Mundipharma; Novartis; Seagen; Spectrum Pharmaceuticals
Research Funding - Acetylon Pharmaceuticals; Celgene; Millennium; Roche; Seagen; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Acetylon Pharmaceuticals; Millennium; Mundipharma; Seagen; Spectrum Pharmaceuticals
 
Barbara Pro
Research Funding - Celgene (Inst); Genentech (Inst); Janssen (Inst); Pharmacyclics (Inst); Seagen (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Seagen
 
Tim Illidge
Honoraria - Takeda
Consulting or Advisory Role - Seagen; Takeda
Research Funding - Seagen (Inst)
 
Lorenz H. Trumper
Consulting or Advisory Role - Seagen
Research Funding - Seagen (Inst)
 
Emily K. Larsen
Employment - Seagen
Stock and Other Ownership Interests - Seagen
 
Thomas John Manley
Employment - Seagen
Stock and Other Ownership Interests - Seagen